openPR Logo
Press release

ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2026

08-07-2018 04:05 PM CET | Health & Medicine

Press release from: CMI Research

ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2026

The Global ENT Disorder Treatment Market, by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 9,521.1 million in 2016 and is projected to exhibit a CAGR of 3.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The ENT Disorders treatment market is expected to gain significant traction with increasing incidence of ENT disorders and increasing environmental pollution globally. According to an article published by Harvard Medical School and Teaching Hospital, 2017, over 360 million people across the globe are suffering from hearing loss and over half of this population can be treated with proper medication and care.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1326

Development novel treatments for ENT disorders through extensive R&D is expected to be a major factor driving the global ENT disorder treatment market growth

Manufacturers are focusing on development new and innovative treatments and therapies for ENT disorders for both adult and pediatric segments, in order to maintain their market share. For instance, Otonomy, Inc. — a U.S. based drug manufacturer — received FDA approval for OTIPRIO (ciproflaxin otic suspension) in December 2015, for treatment of pediatric patients suffering with bilateral otitis media with effusion. In May 2012, Meda Pharmaceuticals received FDA approval for dymista (azelastine hydrochloride and fluticasone propionate) for the treatment of seasonal allergic rhinitis that can be consumed by intranasal administration or sprayed suspension. Furthermore, in June 2017, Inspire Medical Systems received FDA approval for Inspire 3028 neurostimulator for the treatment of obstructive sleep apnea.

Browse 42 Market Data Tables and 36 Figures spread through 161 Pages and in-depth TOC on “Global ENT Disorder Treatment Market”- by Treatment Type (Devices (Hearing Aid Devices, Voice Prosthesis, Nasal Splints, Hearing Implants and Others) and Drug Type(Antibiotics, Antihistamines, Steroids, Anti-inflammatory Drugs, Others)), By Organ Type (Ear, Nose and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Key players are focusing on strategic merger and acquisition strategies for development and commercialization of novel ENT therapeutics and medical devices. For instance, December 2017, Entellus Medical, Inc. — a leader in ENT drugs segment — entered a definitive merger agreement with Stryker Corporation for development of effective ENT solutions through collaboration. Moreover, in in July 2017, Entellus Medical acquired Spirox, Inc. a privately held company that manufactures, develops and markets ENT medical devices.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1326

Key Takeaways of the ENT Disorder Treatment Market:

The global ENT disorder treatment market is expected to exhibit a CAGR of 3.22% over the forecast period, owing to rising incidence of ENT disorders coupled with deteriorating environmental factors such as rising air and noise pollution across the globe. For instance, according to CDC 2016, 30 million people in the U.S. were exposed to extremely high decibels sound levels, at workplace, leading to hearing disorders.

Among treatment type segment, drug segment holds a dominant position in the global ENT disorder treatment market. This is owing to drug being the first line of treatment in most of the ENT disorders.

Among end users, hospital segment holds a dominant position in the global ENT disorder treatment market, as most of the surgical, non-surgical as well as consultation procedures are conducted at hospitals.

Some of the major players operating in the global ENT disorder treatment market include Sanofi, AstraZeneca plc, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddys Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1326

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2026 here

News-ID: 1167153 • Views: 369

More Releases from CMI Research

Wearable Patch Industry Adoption of Innovative Offerings and Forecast 2019-2027
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Wearable Patch Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the
Hemodialysis Industry Showcase Attractive Growth Opportunities and Forecast 2019 …
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Hemodialysis Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the global
Breast Reconstruction Industry Positive Long-Term Growth Outlook and Forecast 20 …
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Breast Reconstruction Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the
Elderly Nutrition Industry Emerging Growth, Trend and Forecast to 2027
Coherent Market Insights has recently updated its massive report catalogue by adding a fresh study titled "Global Elderly Nutrition Market: Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019-2027". This business intelligence study On current Growth as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the

All 5 Releases


More Releases for ENT

United States ENT Endoscopes Market Report
In this report, the United States ENT Endoscopes market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
ENT Chairs Market – Global Industry Insights, Trends
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
ENT Chairs Market – Global Industry Insights, 2025
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
2017 ENT Devices Market Embraces Advancements
In this report, the global ENT Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENT Devices in these regions, from 2012 to 2022 (forecast), covering North
ENT 2017_Conference_New Orleans, USA
On behalf of Allied Academies, it is our pleasure to invite you all to the “5th American Otolaryngology - ENT Surgery Conference” during November 09-10, 2017. New Orleans, Louisiana, USA. The International conference offers a focus on “Emerging Trends and Innovations in Otolaryngology-ENT”. For more details, visit us: http://ent.alliedacademies.com/ The ENT 2017 will cover the various key issues related to Head and Neck such as Head and Neck Surgery, Otolaryngology (ENT),
Jacksonville ENT Surgery welcomes new Medical Assistant
Jacksonville, Fla., Feb. 15, 2017 – Jacksonville ENT Surgery is pleased to welcome Lejla Juklo to their team as a certified medical assistant. Juklo will be responsible for taking a patient’s medical history, vital signs, preparing rooms for patient exams, assisting with allergy testing, CT scans and assisting the providers. She will be rotating between Jacksonville ENT Surgery’s five locations in Jacksonville, Jacksonville Beach and Lake City. Juklo is a